MedTrace Logo

An Assessment of Fentanyl Dose Requirements in Opioid-maintained Individuals

NCT01358500 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-02-06

No results posted yet for this study

Summary

This study seeks to determine the suitable doses of fentanyl with acceptable adverse effect and safety profile in opioid-dependent patients. The investigators anticipate that a well tolerated dose of fentanyl which produces demonstrable analgesia will be found and will be related to the patient's maintenance opioid dose.

Conditions

  • Opioid Dependence

Interventions

DRUG

Fentanyl

Intravenous infusion using STANPUMP

Sponsors & Collaborators

  • University of Adelaide

    lead OTHER

Principal Investigators

  • Paul E Rolan, MD · University of Adelaide

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01358500 on ClinicalTrials.gov